Wire flash
FinanceWalmart reaches settlement with DOJ over opioid prescription lawsuit
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Walmart has reached a settlement with the U.S. Department of Justice (DOJ) in a lawsuit that accused its pharmacies of contributing to the opioid epidemic by unlawfully dispensing prescriptions. The lawsuit alleged that Walmart failed to properly screen and report suspicious opioid prescriptions, thereby fueling the nationwide crisis. The settlement resolves claims that the retail giant's pharmacies violated the Controlled Substances Act. Details of the settlement terms, including financial penalties or compliance measures, have not yet been disclosed. This development marks a significant legal resolution in the ongoing efforts to hold major pharmacy chains accountable for their role in the opioid crisis.
Source report
JUST IN — Walmart has reached a settlement with the U.S. Department of Justice (DOJ) in a lawsuit alleging that its pharmacies contributed to the opioid epidemic by unlawfully dispensing prescriptions.
The lawsuit accused Walmart of failing to properly oversee prescription dispensing at its pharmacies, thereby fueling the nationwide opioid crisis. Details of the settlement, including financial terms, have not yet been disclosed.
This development marks a significant legal resolution for the retail giant, which had faced federal scrutiny over its role in the opioid epidemic.
Source
PolymarketNeutral / independent
Part of this Story
Walmart pays $50 million to settle U.S. DOJ opioid dispensing lawsuit